HDAC8: a multifaceted target for therapeutic interventions

Histone deacetylase 8 (HDAC8) is a class I histone deacetylase implicated as a therapeutic target in various diseases, including cancer, X-linked intellectual disability, and parasitic infections. It is a structurally well-characterized enzyme that also deacetylates nonhistone proteins. In cancer, H...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Chakrabarti, Alokta (VerfasserIn) , Witt, Olaf (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: July 2015
In: Trends in pharmacological sciences
Year: 2015, Jahrgang: 36, Heft: 7, Pages: 481-492
ISSN:1873-3735
DOI:10.1016/j.tips.2015.04.013
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1016/j.tips.2015.04.013
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0165614715000899
Volltext
Verfasserangaben:Alokta Chakrabarti, Ina Oehme, Olaf Witt, Guilherme Oliveira, Wolfgang Sippl, Christophe Romier, Raymond J. Pierce, Manfred Jung

MARC

LEADER 00000caa a2200000 c 4500
001 1556110324
003 DE-627
005 20230426153647.0
007 cr uuu---uuuuu
008 170330s2015 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.tips.2015.04.013  |2 doi 
035 |a (DE-627)1556110324 
035 |a (DE-576)48611032X 
035 |a (DE-599)BSZ48611032X 
035 |a (OCoLC)1340969128 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Chakrabarti, Alokta  |e VerfasserIn  |0 (DE-588)112875651X  |0 (DE-627)883194139  |0 (DE-576)486051692  |4 aut 
245 1 0 |a HDAC8  |b a multifaceted target for therapeutic interventions  |c Alokta Chakrabarti, Ina Oehme, Olaf Witt, Guilherme Oliveira, Wolfgang Sippl, Christophe Romier, Raymond J. Pierce, Manfred Jung 
264 1 |c July 2015 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 30.03.2017 
520 |a Histone deacetylase 8 (HDAC8) is a class I histone deacetylase implicated as a therapeutic target in various diseases, including cancer, X-linked intellectual disability, and parasitic infections. It is a structurally well-characterized enzyme that also deacetylates nonhistone proteins. In cancer, HDAC8 is a major ‘epigenetic player’ that is linked to deregulated expression or interaction with transcription factors critical to tumorigenesis. In the parasite Schistosoma mansoni and in viral infections, HDAC8 is a novel target to subdue infection. The current challenge remains in the development of potent selective inhibitors that would specifically target HDAC8 with fewer adverse effects compared with pan-HDAC inhibitors. Here, we review HDAC8 as a drug target and discuss inhibitors with respect to their structural features and therapeutic interventions. 
650 4 |a cancer 
650 4 |a Cornelia de Lange syndrome 
650 4 |a HDAC8 
650 4 |a histone deacetylases 
650 4 |a schistosoma 
650 4 |a X-ray crystallography 
700 1 |a Witt, Olaf  |d 1965-  |e VerfasserIn  |0 (DE-588)17275030X  |0 (DE-627)697681750  |0 (DE-576)133607410  |4 aut 
773 0 8 |i Enthalten in  |t Trends in pharmacological sciences  |d Amsterdam [u.a.] : Elsevier Science, 1979  |g 36(2015), 7, Seite 481-492  |h Online-Ressource  |w (DE-627)320490912  |w (DE-600)2011007-8  |w (DE-576)116726067  |x 1873-3735  |7 nnas  |a HDAC8 a multifaceted target for therapeutic interventions 
773 1 8 |g volume:36  |g year:2015  |g number:7  |g pages:481-492  |g extent:12  |a HDAC8 a multifaceted target for therapeutic interventions 
856 4 0 |u http://dx.doi.org/10.1016/j.tips.2015.04.013  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0165614715000899  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20170330 
993 |a Article 
994 |a 2015 
998 |g 17275030X  |a Witt, Olaf  |m 17275030X:Witt, Olaf  |d 910000  |d 910500  |e 910000PW17275030X  |e 910500PW17275030X  |k 0/910000/  |k 1/910000/910500/  |p 3 
999 |a KXP-PPN1556110324  |e 2963165579 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"id":{"zdb":["2011007-8"],"eki":["320490912"],"issn":["1873-3735"]},"recId":"320490912","type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"HDAC8 a multifaceted target for therapeutic interventionsTrends in pharmacological sciences","origin":[{"publisherPlace":"Amsterdam [u.a.]","dateIssuedKey":"1979","dateIssuedDisp":"1979-","publisher":"Elsevier Science"}],"note":["Gesehen am 28.05.20","Ungezählte Beil.: Supplement"],"pubHistory":["1.1979/80 -"],"language":["eng"],"part":{"text":"36(2015), 7, Seite 481-492","volume":"36","extent":"12","year":"2015","pages":"481-492","issue":"7"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Trends in pharmacological sciences","title_sort":"Trends in pharmacological sciences"}]}],"physDesc":[{"extent":"12 S."}],"title":[{"title":"HDAC8","title_sort":"HDAC8","subtitle":"a multifaceted target for therapeutic interventions"}],"note":["Gesehen am 30.03.2017"],"language":["eng"],"person":[{"role":"aut","family":"Chakrabarti","display":"Chakrabarti, Alokta","given":"Alokta"},{"role":"aut","family":"Witt","display":"Witt, Olaf","given":"Olaf"}],"recId":"1556110324","id":{"eki":["1556110324"],"doi":["10.1016/j.tips.2015.04.013"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["Alokta Chakrabarti, Ina Oehme, Olaf Witt, Guilherme Oliveira, Wolfgang Sippl, Christophe Romier, Raymond J. Pierce, Manfred Jung"]},"origin":[{"dateIssuedDisp":"July 2015","dateIssuedKey":"2015"}]} 
SRT |a CHAKRABARTHDAC82015